Global Robot-assisted Surgical Devices Growth Opportunities 2022: AI for Robotic Surgery to Predict Surgical Outcomes and Minimize Variability

Robot-assisted Surgical Devices

The “Global Robot-assisted Surgical Devices (RASD) Growth Opportunities” report has been added to ResearchAndMarkets.com’s offering.

The report estimates the aging population and accompanying retirements to cause a significant physician shortfall of 55,000 to 150,000 by 2030, creating a gap in the healthcare system. Expanding the role of autonomous robots can mitigate the shortage.

The healthcare sector is forecast to expand rapidly with the decentralization of institutions bringing about more offerings with robotic surgeries. Influenced by the growing incidence of lifestyle diseases and demand for affordable healthcare, effective surgery with robotic devices with a favorable decline in treatment costs looks promising.

Robotic technology adoption has improved surgeons’ capabilities with better ergonomics, motion scaling, and tremor filtration, meeting their demand. The need for experience before robotic surgery remains debatable. However, the transition from a laparoscopic surgeon to a robotic surgeon is associated with a shorter learning period. Hence, several medical academic and research institutes in the United States and Europe now offer robotic surgery training programs to ensure more surgeons have expertise and skills with a shorter learning curve.

Hospital spending on capital equipment recorded an upswing early in 2021, signaling a stronger outlook for surgical procedures guided by robotic systems for the coming years. Hospital finances seem to be significantly healthier than they were after the economic downturn following the COVID-19 pandemic onset. The publisher projects leasing to grow as a percentage of sales over time, with deferred revenue increasing in the future as customers access capital through alternative financing arrangements.

The report overviews the global robot-assisted surgical devices (RASD) market and revenue forecast from 2022 to 2026, covering a detailed market segment analysis, including various promising and emerging business models. It offers forecast by product (RASD systems, instruments and accessories, RASD services) and region.

The study analyzes emerging opportunities and technology trends in surgical robot devices and procedures, with an exclusive focus on technologies enabling different market segments. The report also details innovations in different segments, initiatives to improve the overall adoption of surgical robotics technologies, and trends that drive and hinder the market growth.

The trends shaping the industry are:

  • Increase in Demand for Patient-specific Surgeries: Well-informed patients are demanding surgeons for personalized therapies, implants, procedures, and experience.
  • Demand for Better Procedural Efficiencies: Patients demand maximum comfort while requiring minimum physical supervision. The need of the hour is reducing surgery times, better efficiencies, and optimized outcomes.
  • Changing Reimbursement Trends: The shift toward payments based on quality plus cost over procedure-based reimbursement is likely to change the way medical technologies are evaluated and purchased.
  • Changing Dynamics between Participants: Mergers and acquisitions, joint ventures, and leasing models are forecast to shape the industry.
  • Shift to Emerging Economies: Large orthopedic participants are focusing on Asia-Pacific and other emerging economies that are forecast to register growth rates 2 to 3 times higher than developed markets.
  • Demand for Lesser Hospital Time: The focus shifts to technologies that involve lesser hospital time for patients and lead to quicker recoveries.

Key Topics Covered:

Market Overview

  • Segmentation by Application
  • Technology Overview of the Study
  • Next Generation Technology and What it Means for Minimal Invasive Surgery
  • Evolving Roles of Robotics in Surgery
  • AI Enhances Human-robot Interaction (HRI)

Growth Opportunity Analysis

  • Scope of Analysis
  • Segmentation by Application
  • Key Competitors
  • Key Growth Metrics
  • Growth Drivers
  • Growth Restraints
  • Forecast Assumptions
  • Revenue Forecast by Product
  • Revenue Forecast by Region
  • Revenue Forecast Analysis
  • Forecast Analysis by Region
  • Pricing Trends and Forecast Analysis
  • Competitive Environment
  • Revenue Share Analysis

Growth Opportunity Analysis – RASD Systems

  • Key Growth Metrics
  • Revenue and Unit Shipment Forecast
  • Revenue Forecast by Product
  • Revenue Forecast by Region
  • Unit Shipment Forecast by Product
  • Unit Shipment Forecast by Region
  • Forecast Analysis

Growth Opportunity Analysis – Instruments and Accessories

Growth Opportunity Analysis – RASD Services

Changing Paradigms in Surgical Care with Robotics

  • Evolving Roles of Robotics in Surgery
  • Recent Advances in Robotic Surgery
  • AI Enhances HRI
  • AI for Autonomous Robotic Surgery
  • Transition from Multi-port to Single-site Surgery
  • Robotic Surgery Becomes the Standard of Care

Future Use Cases

  • Adoption Criteria for Robot-assisted Surgery
  • Comparative Matrix
  • Opportunities and Development Scenario by Specialty

New Entrants and Changing Ecosystem

  • RASD Portability
  • Connectivity and Telesurgery

Business Models

  • Digital Surgery-as-a-Service
  • Increasing Focus on Microsurgery
  • Future RASD Market Direction

Growth Opportunity Universe

  • AI for Robotic Surgery to Predict Surgical Outcomes and Minimize Variability
  • Telesurgery enabled with Digital Connectivity to Eliminate Latency
  • Improved Dexterity to Enable Quick Patient Recovery
  • New Pricing Models to Improve Adoption
  • Simulation and Training for Enhanced Surgical Outcomes

For more information about this report visit here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version